Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    biopure OR polyheme OR oxycyte OR hemolink OR stanate | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
biopure OR polyheme OR oxycyte OR hemolink OR stanate | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Available Compassionate Use of Stanate (TM) [Stannsoporfin]
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Intervention: Drug: Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
2 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
3 Unknown  A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
Condition: Wounds and Injuries
Interventions: Drug: Hemoglobin-based oxygen carrier-201 (HBOC 201);   Other: Standard of Care
4 Unknown  A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
Condition: Coronary Artery Disease
Intervention: Drug: HBOC-201 (hemoglobin glutamer-250 bovine)

Indicates status has not been verified in more than two years